Music Therapy for Pain Modification in Pediatric Palliative Care
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this within-subjects randomized controlled trial is to determine whether two music therapy interventions are efficacious in reducing pain symptoms, in order to improve the quality of care for children in pediatric hospice. The investigators hypothesize that both music therapy interventions, live guitar and vocal intervention and vibroacoustic intervention, will reduce behavioural pain scores and that behavioural pain scores will correlate with physiological outcome measures.
Full description
Effective pain management in pediatric palliative care is a quality of life issue for patients, families and professionals. Current research supports the use of music therapy to assist with pain management in pediatric medical settings. However, little research has been done to explore the use of music therapy for reducing pain in children with life-limiting neurological impairments or metabolic conditions.
As the first known project to examine the effects of music therapy on pain symptoms with children who have life-limiting neurological impairments or metabolic disorders, this study will expand the evidence-base for practice with this population. It is imperative that an evidence base for music therapy in this area be established, so that the most effective interventions can be provided to these vulnerable children.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Children, ages 1-19, who have been diagnosed with life-limiting neurological impairments and metabolic conditions
- Cognitive functioning level of one year or less will be enrolled in the study
- Receiving respite or symptom management care at the time of admission to the Canuck Place Children's Hospice
- Guardians must be able to provide written consent in English; interpreters will be available if a guardian needs clarification on specific points.
Exclusion criteria
- Children who are actively dying (i.e. admitted for end-of-life care or determined by physicians to require immediate end-of-life care)
- Any history of adverse responses to live or recorded music or to vibroacoustic stimulation
- Severe to profound hearing impairment will be excluded.
Trial design
Primary purpose
Allocation
Interventional model
Masking
13 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal